echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > Beihai Kangcheng's new drug CAN108 for the treatment of Alagille syndrome (NDA/ODR) was accepted by the Taiwan Food and Drug Administration

    Beihai Kangcheng's new drug CAN108 for the treatment of Alagille syndrome (NDA/ODR) was accepted by the Taiwan Food and Drug Administration

    • Last Update: 2022-04-20
    • Source: Internet
    • Author: User
    Tags

    bile acid supplement

    female reproductive diseases
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com